CEP
BIIB icon

Chicago Equity Partners’s Biogen BIIB Stock Holding History

Chicago Equity Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2.38M Buy
+7,525
New +$2.28M 0.24% 106
2019
Q1 		– Sell
-13,584
Closed -$4.09M – 843
2018
Q4 		$4.09M Sell
13,584
-520
-4% -$166K 0.17% 169
2018
Q3 		$4.98M Buy
14,104
+1,489
+12% +$513K 0.15% 186
2018
Q2 		$3.66M Sell
12,615
-3,760
-23% -$1.06M 0.11% 269
2018
Q1 		$4.48M Buy
16,375
+13,560
+482% +$4.21M 0.14% 202
2017
Q4 		$897K Sell
2,815
-100
-3% -$32.1K 0.03% 525
2017
Q3 		$913K Hold
2,915
– – 0.03% 528
2017
Q2 		$791K Sell
2,915
-310
-10% -$82K 0.02% 552
2017
Q1 		$882K Sell
3,225
-65
-2% -$18.4K 0.03% 479
2016
Q4 		$933K Buy
3,290
+145
+5% +$43K 0.02% 470
2016
Q3 		$984K Buy
+3,145
New +$931K 0.03% 435
2016
Q1 		– Sell
-1,790
Closed -$548K – 586
2015
Q4 		$548K Buy
1,790
+170
+10% +$48.8K 0.01% 456
2015
Q3 		$473K Sell
1,620
-2,360
-59% -$779K 0.01% 478
2015
Q2 		$1.61M Sell
3,980
-34,385
-90% -$13.8M 0.04% 224
2015
Q1 		$16.2M Buy
38,365
+7,990
+26% +$3.15M 0.43% 81
2014
Q4 		$10.3M Buy
30,375
+11,630
+62% +$3.76M 0.28% 102
2014
Q3 		$6.2M Buy
+18,745
New +$6.18M 0.16% 135
2014
Q2 		– Sell
-23,265
Closed -$7.12M – 450
2014
Q1 		$7.12M Sell
23,265
-4,980
-18% -$1.58M 0.2% 136
2013
Q4 		$7.9M Buy
28,245
+145
+0.5% +$37.5K 0.24% 115
2013
Q3 		$6.76M Sell
28,100
-1,730
-6% -$387K 0.21% 125
2013
Q2 		$6.42M Buy
+29,830
New +$6.37M 0.2% 124

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Equity Partners's BIIB Position: Q1 2020 in Review

Chicago Equity Partners opened a new position in Biogen (BIIB) in Q1 2020: 7,525 shares worth $2.38M. The stake represents 0.24% of the portfolio and ranks #106 among its holdings. This is a return to the name: Chicago Equity Partners previously reported a position in BIIB as recently as Q4 2018.

Chicago Equity Partners first reported a position in BIIB in Q2 2013 and has held it in 21 quarters since. The position peaked at $16.2M in Q1 2015. 1,099 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Chicago Equity Partners held 7,525 shares of Biogen worth $2.38M as of Q1 2020.
  • Biogen was a new Chicago Equity Partners position in Q1 2020.
  • Biogen made up 0.24% of Chicago Equity Partners's portfolio in Q1 2020, its #106 holding.
  • Chicago Equity Partners first reported a position in Biogen in Q2 2013 and has held it in 21 quarters since.
  • Chicago Equity Partners's Biogen position peaked at $16.2M in Q1 2015.
  • 1,099 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.